How to measure intraocular pressure (IOP) in a person with blepharospasm?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 21, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Measuring IOP in Blepharospasm

In patients with blepharospasm, use rebound tonometry (iCare) or ocular response analyzer as first-line methods, as these devices do not require topical anesthesia and minimize patient discomfort during involuntary eyelid spasms. 1

Optimal Tonometry Methods for Blepharospasm

First-Line Techniques (No Anesthesia Required)

  • Rebound tonometry is the preferred method because it requires no topical anesthesia, uses rapid probe contact (0.05 seconds), and can be performed quickly between spasms 1
  • The device fires a magnetized plastic-tipped probe against the cornea at 0.25 m/sec and analyzes deceleration rate to calculate IOP, requiring 6 measurements for accuracy 1
  • Ocular response analyzer is an excellent alternative as it uses a collimated air pulse without requiring topical anesthesia, measures corneal biomechanical properties, and calculates "corneal-compensated" IOP 1

Second-Line Techniques (Anesthesia Required)

If rebound tonometry or ocular response analyzer are unavailable, consider these alternatives that require topical anesthesia 2:

  • Pneumotonometer uses a 5-mm fenestrated silicone tip that conforms to the cornea, generates 40 readings per second, and may be easier to apply during brief periods between spasms 1
  • Dynamic contour tonometer (Pascal) requires 6 seconds of stable contact and calculates IOP independent of corneal properties, but may be challenging with active spasms 1
  • Goldmann applanation tonometry is the gold standard for normal corneas but requires sustained patient cooperation and topical anesthesia, making it difficult in active blepharospasm 3, 2

Clinical Considerations Specific to Blepharospasm

Timing of Measurement

  • Measure IOP after botulinum toxin A (BTX-A) treatment when possible, as eyelid pressure and IOP are significantly reduced following injection 4
  • Eyelid pressure in blepharospasm patients (35.3 mmHg upper, 37.8 mmHg lower) is significantly higher than normal controls (31.0 mmHg upper, 29.9 mmHg lower), which can artificially elevate IOP readings 4
  • After BTX-A treatment, eyelid pressure decreases to near-normal levels (29.9 mmHg upper, 32.8 mmHg lower), and IOP decreases from 15.1 mmHg to 14.5 mmHg 4

Important Pitfalls

  • Avoid measuring during active spasm, as forceful eyelid closure can transiently elevate IOP and produce falsely high readings 4
  • Lower eyelid pressure correlates significantly with IOP (P = 0.0435), so measurements taken during involuntary lid closure may overestimate true baseline IOP 4
  • Blepharospasm itself is not a risk factor for glaucoma development, so elevated IOP readings during spasms should not trigger unnecessary glaucoma treatment 5

Practical Algorithm

  1. First attempt: Use rebound tonometry (iCare) or ocular response analyzer—no anesthesia needed, rapid measurement possible between spasms 1, 3
  2. If unavailable: Apply topical anesthesia 2 and use pneumotonometer for quick measurements with conforming tip 1
  3. If measurements inconsistent: Consider scheduling measurement after BTX-A treatment when spasms are controlled 4
  4. Maintain consistency: Use the same device for serial measurements, as switching between tonometry methods introduces variability that can mask true IOP changes 3

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Measuring Intraocular Pressure Accurately

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Risk of glaucoma among patients with benign essential blepharospasm.

Ophthalmic plastic and reconstructive surgery, 2010

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.